SLC38A2 and succinic semialdehyde dehydrogenase deficiency: These studies, the first to investigate the molecular impact of dietary glutamine supplementation in SSADHD, showed that supplementation significantly impacted the expression of several genes: slc7a5 (up), slc38a2 (down), glul (up), and gls (down).